U.S. Marine and Shipping Stock News

In recent days, Toast, Inc. has been highlighted as a core software and payments layer for the restaurant industry, now supporting 156,000 locations and processing US$51.50 billion in gross payment volume, while attracting increased attention from investors following sector volatility and commentary on enterprise software resilience amid AI adoption. What stands out is how Toast’s unified platform and expanding enterprise and international footprint are reinforcing its role as an embedded...

HA Sustainable Infrastructure Capital recently redeemed all US$450,000,000 of its 8.000% senior notes due 2027, using proceeds from new 6.000% green senior unsecured notes due 2036 and 7.125% green junior subordinated notes due 2056. This refinancing not only lengthens the company’s debt maturity profile but also aligns its funding base more closely with sustainability-focused investment projects. Next, we will examine how replacing higher‑coupon 2027 senior debt with longer‑dated green...

If you are wondering whether Wealthfront's current share price reflects its true worth, you are not alone; many investors are asking the same question. The stock last closed at US$8.79, with returns of 6.4% over the past 7 days and 1.4% over the past 30 days, while the year to date return sits at a 33.5% decline. Recent coverage has focused on Wealthfront's position in diversified financials and how it fits into broader themes in automated investing and digital wealth management. This...

XPeng has launched its second generation Vision Language Action smart driving system, VLA 2.0, aimed at fully autonomous driving capabilities. Volkswagen will be the first external customer for VLA 2.0, marking a new technology partnership between the two automakers. XPeng plans to roll out fully autonomous robotaxis powered by VLA 2.0 as part of its commercial push in AI driven mobility. XPeng, listed as NYSE:XPEV, is putting this move in front of investors at a time when its share price...

In early March 2026, Helus Pharma, a Cybin company, reported positive topline Phase 2 results for HLP004 as an adjunctive treatment for adults with moderate-to-severe generalized anxiety disorder who remained symptomatic despite standard antidepressant therapy, showing clinically meaningful anxiety score reductions, durable response and remission rates, and a favorable tolerability profile. The findings highlight HLP004’s commercially practical intramuscular administration with short...

Life Time Group Holdings (NYSE:LTH) has approved a new $500 million share repurchase program. The buyback plan targets the company's common stock and is intended to support long term shareholder value. This authorization adds a fresh capital allocation lever for the fitness and lifestyle operator. Life Time Group Holdings, trading at $26.12 per share, is coming off a mixed share price run, with a 51.2% gain over three years but a 13.3% decline over the past year. In the shorter term, the...

CRISPR Therapeutics reported a threefold increase in Casgevy patient initiations for sickle cell disease and beta thalassemia over the past year. The company highlighted ongoing commercial rollout progress alongside continued net losses. Management pointed to a strong cash position as support for both Casgevy expansion and further R&D. CRISPR Therapeutics, trading on NasdaqGM:CRSP, is in the spotlight as Casgevy gains early traction in the gene therapy market. The stock closed at $57.33,...

In late February 2026, Recursion Pharmaceuticals reported fourth-quarter 2025 revenue of US$35.54 million with a quarterly net loss of US$108.12 million, and around the same time filed a US$300 million at-the-market follow-on equity offering plus a US$68.57 million shelf registration tied to an ESOP. Shortly after these filings, Director Blake Borgeson sold 170,000 Class A shares while still retaining more than 6.25 million shares, drawing attention to insider sentiment alongside the...

Event overview and why NRG Energy is on investors’ radar NRG Energy (NRG) has attracted fresh attention after a strong 1 year total return of 78.24%, standing out against more muted recent moves over the past week and month. That contrast between short term pullback and longer term strength is prompting investors to reassess how the company’s US$30,713.0m in revenue and US$797.0m in net income line up with current pricing. See our latest analysis for NRG Energy. At a share price of US$160.46,...

Assessing Acushnet Holdings after recent share price moves Acushnet Holdings (GOLF) has recently seen mixed share price performance, with a 2.3% decline over the past day and a 5.6% decline over the past week, alongside gains over the past 3 months and year. See our latest analysis for Acushnet Holdings. Putting that into context, the recent 1-day and 7-day share price declines sit against a stronger 90-day share price return of 16.4% and a 1-year total shareholder return of 44.0%. This...

JBS stock snapshot and recent performance JBS (NYSE:JBS) has recently drawn investor attention as its shares trade around $15.65, with returns showing mixed short term moves and a positive shift over the past 3 months and year to date. See our latest analysis for JBS. Despite a recent 1-day share price return decline of 4.16% and a 7-day share price return decline of 5.89%, JBS still shows a 90-day share price return of 9.06% and a year to date share price return of 10.37%. This suggests...

Lockheed Martin (NYSE:LMT) is partnering with Mitsubishi Electric to supply anti jamming payloads for Japan's next generation defense satellites. The company is working with Teradar to test terahertz sensing technology for battlefield perception in challenging environments. Lockheed Martin is collaborating with Xanadu on quantum machine learning focused on defense and national security applications. For you as an investor looking at NYSE:LMT, these agreements sit in the core of the...

Oil price shock and inflation fears hit Atmus Filtration Technologies (ATMU) Atmus Filtration Technologies (ATMU) came under pressure after crude oil prices jumped on escalating conflict with Iran, raising concerns about renewed inflation and the prospect of more challenging central bank interest rate decisions. See our latest analysis for Atmus Filtration Technologies. Despite the latest 2.97% 1 day share price decline to $61.84, Atmus Filtration Technologies still has a 1 month share price...

Huntington Bancshares at a glance Huntington Bancshares (HBAN) has drawn attention after recent share price weakness, with the stock down about 9% over the past month and modestly lower over the past 3 months. At a last close of $16.68, the regional bank carries a value score of 3 and reports annual revenue of $7,692.0 and net income of $2,087.0, both stated with positive annual growth rates. See our latest analysis for Huntington Bancshares. The recent 9.3% 30 day share price decline and...

Zoom Communications (ZM) is back in focus after a sector wide rally spotlighted enterprise software names, just days after the company reported quarterly results that exceeded its guidance midpoint for a third straight time. See our latest analysis for Zoom Communications. Even after the sector rally and the latest earnings beat, Zoom’s share price of US$77.33 sits below its recent highs, with a 30 day share price return of 12.85% decline and a year to date share price return of 7.19%...

Executives at Travelers Companies (NYSE:TRV) have recently carried out significant insider share sales, drawing attention to management's trading activity. The company has reported strong operating performance supported by underwriting gains, higher investment income, and efficiencies linked to AI tools. Travelers Companies sits at a current share price of $306.64. The stock is up 21.7% over the past year, 85.7% over the past 3 years, and 117.4% over the past 5 years. For investors looking...

Las Vegas Sands (LVS) has put fresh leadership at the center of its story, with Patrick Dumont now serving as chairman, chief executive officer, president, and treasurer, alongside new five year agreements for other senior executives. See our latest analysis for Las Vegas Sands. The leadership reshuffle lands at a time when the share price has eased back, with a 90 day share price return of 16.77% decline and a year to date share price return of 15.44% decline. At the same time, the 1 year...

OmniAb (OABI) has posted its FY 2025 numbers with Q4 revenue of US$8.4 million and a basic EPS loss of US$0.11, alongside a trailing twelve month revenue figure of US$18.7 million and a basic EPS loss of US$0.57. Over recent quarters, the company has reported quarterly revenue in a range between US$2.2 million and US$10.8 million, while basic EPS losses have ranged from US$0.11 to US$0.17, leaving margins in loss-making territory and keeping the focus on how efficiently that revenue is being...

If you are wondering whether Power Integrations is attractively priced right now, it helps to separate the share price story from what the underlying valuation is actually saying. The stock closed at US$47.81 most recently, after a 5.7% gain over the last 30 days, with a 28.2% return year to date, alongside an 18.3% decline over the past year and a 40.0% decline over five years. Recent attention on Power Integrations has centered on its position in the semiconductor space and how investors...

Lam Research (LRCX) shares dropped after renewed concerns about Middle East tensions, with investors reacting to potential energy price shocks, higher liquefied natural gas costs in South Korea, and possible new AI chip export rules. See our latest analysis for Lam Research. The recent 3.7% one day share price drop to US$214.68 and 10.2% 7 day share price decline come after months of strong momentum, with a 35.3% 90 day share price return and very large multi year total shareholder returns...

In late February 2026, Stoke Therapeutics and Biogen reported in The New England Journal of Medicine that their investigational Dravet syndrome therapy zorevunersen produced substantial, durable reductions in seizures and multi‑year cognitive and behavioral benefits, while Stoke also outlined a Phase 3 EMPEROR timeline and plans for a rolling FDA submission. These clinical and regulatory updates suggest zorevunersen could shift treatment expectations in Dravet syndrome and intensify focus on...

Darden Restaurants recently updated investors on its past quarter, outlining softer guest traffic, selective price increases, and tight cost control across Olive Garden, LongHorn Steakhouse, and other brands to protect industry-leading margins. Management’s emphasis on disciplined promotions and maintaining strong restaurant-level profitability, while still funding dividends, highlights Darden’s role as a relatively resilient, income-oriented casual dining operator. We’ll now examine how...

In late February 2026, Intuit Inc. reported higher revenue and earnings for its fiscal second quarter and first half, reaffirmed full‑year guidance, and approved a US$1.20 quarterly dividend per share, a 15% increase from the prior year period. At the same time, Intuit’s new multi‑year AI partnership with Anthropic aims to embed custom financial AI agents across mid‑market businesses and consumer experiences, potentially deepening usage of its TurboTax, QuickBooks, Credit Karma, and...

Why Aeluma (ALMU) Is Back on Investors’ Radar Recent analyst commentary on Aeluma (ALMU), linking the company to favorable read-through from Nvidia’s optical investments, has sparked fresh interest following the stock’s short-term move of about 4.88%. See our latest analysis for Aeluma. That 4.88% short-term move around the recent analyst commentary sits against a share price of US$15.72 and a softer near term pattern, with the 1-day, 7-day and 90-day share price returns all in decline, even...